We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$12.3B
AUM Growth
+$227M
Cap. Flow
-$346M
Cap. Flow %
-2.81%
Top 10 Hldgs %
24.75%
Holding
2,377
New
669
Increased
496
Reduced
623
Closed
582

Top Sells

Rank Stock Value
1
NI icon
NiSource
NI
+$77.7M
2
LIN icon
Linde
LIN
+$71M
3
DTE icon
DTE Energy
DTE
+$57.1M
4
FCX icon
Freeport-McMoran
FCX
+$51.7M
5
FDX icon
FedEx
FDX
+$44.9M

Sector Composition

Rank Sector Weight
1 Industrials 11.05%
2 Technology 9.71%
3 Healthcare 9.12%
4 Real Estate 6.85%
5 Utilities 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUBS icon
2026
HubSpot
HUBS
$12B
-22,308
Closed -$9.56M
HVT icon
2027
Haverty Furniture Companies
HVT
$427M
-15,696
Closed -$501K
IBM icon
2028
IBM
IBM
$222B
-61,210
Closed -$8.02M
IBP icon
2029
Installed Building Products
IBP
$6.56B
-30,800
Closed -$3.51M
IBRX icon
2030
ImmunityBio
IBRX
$8.26B
-10,262
Closed -$19K
ICE icon
2031
Intercontinental Exchange
ICE
$90.5B
-41,292
Closed -$4.31M
ICL icon
2032
ICL Group
ICL
$7.49B
-39,168
Closed -$266K
IDYA icon
2033
IDEAYA Biosciences
IDYA
$3.83B
-24,330
Closed -$334K
IE icon
2034
Ivanhoe Electric
IE
$1.8B
-35,492
Closed -$431K
IDXX icon
2035
Idexx Laboratories
IDXX
$43.9B
-11,286
Closed -$5.64M
IESC icon
2036
IES Holdings
IESC
$27.3B
-5,998
Closed -$258K
IGMS
2037
DELISTED
IGM Biosciences
IGMS
-59,650
Closed -$820K
IHRT icon
2038
iHeartMedia
IHRT
$432M
-52,933
Closed -$206K
ILMN icon
2039
Illumina
ILMN
$33.1B
-25,047
Closed -$5.67M
INDB icon
2040
Independent Bank
INDB
$3.97B
-21,760
Closed -$1.43M
INFA
2041
DELISTED
Informatica
INFA
-58,030
Closed -$952K
INMD icon
2042
InMode
INMD
$867M
-49,200
Closed -$1.57M
INSW icon
2043
International Seaways
INSW
$4.93B
-52,660
Closed -$2.19M
IONS icon
2044
Ionis Pharmaceuticals
IONS
$9.93B
-265,330
Closed -$9.48M
IOSP icon
2045
Innospec
IOSP
$2.31B
-8,946
Closed -$918K
IQV icon
2046
IQVIA
IQV
$42.8B
-51,922
Closed -$10.3M
IRTC icon
2047
iRhythm Holdings
IRTC
$4.24B
-17,654
Closed -$2.19M
JAMF
2048
DELISTED
Jamf
JAMF
-109,323
Closed -$2.12M
JAZZ icon
2049
Jazz Pharmaceuticals
JAZZ
$16.5B
-10,205
Closed -$1.49M
JBGS
2050
JBG SMITH
JBGS
$732M
-229,060
Closed -$3.45M

Similar funds

Michael Gelband's Q2 2023 Portfolio in Review

As of Q2 2023, Michael Gelband held 2,377 positions worth $12.3B, up 1.9% from $12.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Michael Gelband's Q2 2023 filing shows 669 new, 496 increased, 623 reduced and 582 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 364,360 shares worth $75.5M. The largest sale was NiSource, an estimated $77.7M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

  • Michael Gelband's largest Q2 2023 buy was Pioneer Natural Resource Co.: 364,360 shares worth $75.5M.
  • Michael Gelband added most to Global Payments in Q2 2023, an estimated $308M increase.
  • Michael Gelband's biggest Q2 2023 reduction was NiSource, cutting an estimated $77.7M.
  • Michael Gelband fully exited L3Harris in Q2 2023, selling an estimated $44.7M.
  • Michael Gelband's ten largest holdings make up 25% of its $12.3B portfolio in Q2 2023.
  • Michael Gelband opened 669 new positions and closed 582 in Q2 2023.
  • Michael Gelband's portfolio value rose 1.9% quarter-over-quarter to $12.3B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.